Roberto de Ponti
Direktor/Vorstandsmitglied bei OncoResponse, Inc.
Profil
Roberto de Ponti is currently the Director of Communications & Business Development at Helsinn Healthcare SA, the Director at OncoResponse, Inc., the Director at Fore Biotherapeutics, Inc., the Director at Roca Therapeutics SAS, the Managing Director & General Partner at Helsinn Healthcare SA, the Partner at Stirling Square Capital Partners LLP, and a member of the Investment Committee at Claris Ventures Sgr SpA.
Previously, he held positions as the Senior Director at Pfizer Pharmaceuticals, Inc., the Vice President at Nerviano Medical Sciences SRL, and as a Principal at Indena SpA and Boehringer Mannheim Corp.
(California).
He also served as a Board Member at Amal Therapeutics SA, Greenbone Ortho SRL, QuantuMDx Group Ltd., and GT Gain Therapeutics SA. Additionally, he was a Principal at 3B Future Health Fund S.A.
SICAR.
Aktive Positionen von Roberto de Ponti
| Unternehmen | Position | Beginn |
|---|---|---|
Helsinn Healthcare SA
 Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland. | Public Communications Contact | - |
OncoResponse, Inc.
 OncoResponse, Inc. BiotechnologyHealth Technology OncoResponse, Inc. discovers cancer immunotherapies by interrogating the human immune system. The firm identifies elite responders to immunotherapy and screens the adaptive immune system to discover antibodies with reactivity. The company was founded by Clifford J. Stocks, Kristine Swiderek and Steven H. Gillis in 2015 and is headquartered in Seattle, WA. | Direktor/Vorstandsmitglied | 01.09.2016 |
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Direktor/Vorstandsmitglied | - |
Roca Therapeutics SAS
 Roca Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Roca Therapeutics SAS is a French company that engages in research and drug development in the fields of oncology, ophthalmology, and immunology. The company is based in Nice, France. The company was founded in 2021. The CEO is Maeva Dufies. | Direktor/Vorstandsmitglied | - |
Claris Ventures Sgr SpA
 Claris Ventures Sgr SpA Investment ManagersFinance Claris Ventures Sgr SpA (Claris Ventures) is a venture capital firm founded in 2019 by Pietro Puglisi and Ciro Spedaliere. The firm is headquartered in Turin, Italy. | Berater | 01.09.2020 |
Stirling Square Capital Partners LLP
 Stirling Square Capital Partners LLP Investment ManagersFinance Stirling Square Capital Partners LLP (Stirling Square Capital Partners) is a private equity firm founded in 2002 by Stefano Bonfiglio and Gregario Napoleone. The firm is headquartered in London, United Kingdom. | Private Equity Investor | - |
Helsinn Healthcare SA /Venture/
 Helsinn Healthcare SA /Venture/ Investment ManagersFinance 3B FUTURE HEALTH VENTURES SARL (3B Future Health Ventures) is a venture capital subsidiary of Helsinn Healthcare SA founded in 2016. The firm is headquartered in Monaco, Luxembourg. | Private Equity Investor | 01.01.2022 |
Ehemalige bekannte Positionen von Roberto de Ponti
| Unternehmen | Position | Ende |
|---|---|---|
Greenbone Ortho SRL
 Greenbone Ortho SRL BiotechnologyHealth Technology Greenbone Ortho SRL develops a wood-derived bone implants technology to generate biomimetic implant suitable to address non-union fractures. It offers GreenBone that reproduce chemical composition and thee-dimensional architecture of natural tissues. The company was founded by Lorenzo Pradella in 2014 and is headquartered in Faenza, Italy. | Direktor/Vorstandsmitglied | 02.10.2022 |
QuantuMDx Group Ltd.
 QuantuMDx Group Ltd. Electronic Equipment/InstrumentsElectronic Technology QuantuMDx Group Ltd. develops devices for diagnostics detection. The firm offers DNA-XT, Under The Tree Diagnostics, Q-POC, and Internet of Life. The company was founded by Jonathan O'Halloran, Elaine Warburton, and Julian Warburton in March 2008 and is headquartered in Newcastle upon Tyne, the United Kingdom. | Direktor/Vorstandsmitglied | 02.02.2020 |
| ░░ ░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 16 |
|---|---|
Helsinn Healthcare SA
Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland. | Health Technology |
Nerviano Medical Sciences SRL
 Nerviano Medical Sciences SRL Pharmaceuticals: MajorHealth Technology Nerviano Medical Sciences SRL provides pharmaceutical services. The company is headquartered in Nerviano, Italy. | Health Technology |
Stirling Square Capital Partners LLP
Stirling Square Capital Partners LLP Investment ManagersFinance Stirling Square Capital Partners LLP (Stirling Square Capital Partners) is a private equity firm founded in 2002 by Stefano Bonfiglio and Gregario Napoleone. The firm is headquartered in London, United Kingdom. | Finance |
Pfizer Pharmaceuticals, Inc.
 Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products. | Health Technology |
Indena SpA
 Indena SpA Pharmaceuticals: MajorHealth Technology Indena SpA provides research and development of medicinal products from plants. It offers products to the pharmaceutical, health-food, and personal care industries. The firm provides anti-cancer drugs, which are produced to US-FDA, ICH and EU standards and manufacturing facilities. The company was founded in 1921 and is headquartered in Milan, Italy. | Health Technology |
| Boehringer Mannheim Corp. (California) | |
Amal Therapeutics SA
 Amal Therapeutics SA BiotechnologyHealth Technology Amal Therapeutics SA engages in the development of peptide-based therapeutic cancer vaccines. It offers KISMA, a novel peptide/protein-based immunization technology platform, which is self-adjuvanting and enables the assembly within one chimeric fusion protein of elements essential to generate potent immunity. The company was founded by Madiha Derouazi on September 3, 2012 and is headquartered in Geneva, Switzerland. | Health Technology |
OncoResponse, Inc.
OncoResponse, Inc. BiotechnologyHealth Technology OncoResponse, Inc. discovers cancer immunotherapies by interrogating the human immune system. The firm identifies elite responders to immunotherapy and screens the adaptive immune system to discover antibodies with reactivity. The company was founded by Clifford J. Stocks, Kristine Swiderek and Steven H. Gillis in 2015 and is headquartered in Seattle, WA. | Health Technology |
Fore Biotherapeutics, Inc.
Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Health Technology |
Helsinn Healthcare SA /Venture/
Helsinn Healthcare SA /Venture/ Investment ManagersFinance 3B FUTURE HEALTH VENTURES SARL (3B Future Health Ventures) is a venture capital subsidiary of Helsinn Healthcare SA founded in 2016. The firm is headquartered in Monaco, Luxembourg. | Finance |
Greenbone Ortho SRL
Greenbone Ortho SRL BiotechnologyHealth Technology Greenbone Ortho SRL develops a wood-derived bone implants technology to generate biomimetic implant suitable to address non-union fractures. It offers GreenBone that reproduce chemical composition and thee-dimensional architecture of natural tissues. The company was founded by Lorenzo Pradella in 2014 and is headquartered in Faenza, Italy. | Health Technology |
3B Future Health Fund S.A. SICAR
 3B Future Health Fund S.A. SICAR Investment ManagersFinance 3B Future Health Fund S.A. SICAR invest in companies located in Luxembourg. The fund targets companies operating in the fields of innovative technologies, cancer therapeutics & diagnostics, cancer supportive care, metabolic & gastrointestinal disorders, and dermatology conditions. It provides financing for early stage transactions. | Finance |
QuantuMDx Group Ltd.
QuantuMDx Group Ltd. Electronic Equipment/InstrumentsElectronic Technology QuantuMDx Group Ltd. develops devices for diagnostics detection. The firm offers DNA-XT, Under The Tree Diagnostics, Q-POC, and Internet of Life. The company was founded by Jonathan O'Halloran, Elaine Warburton, and Julian Warburton in March 2008 and is headquartered in Newcastle upon Tyne, the United Kingdom. | Electronic Technology |
GT Gain Therapeutics SA
 GT Gain Therapeutics SA Pharmaceuticals: MajorHealth Technology GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland. | Health Technology |
Claris Ventures Sgr SpA
Claris Ventures Sgr SpA Investment ManagersFinance Claris Ventures Sgr SpA (Claris Ventures) is a venture capital firm founded in 2019 by Pietro Puglisi and Ciro Spedaliere. The firm is headquartered in Turin, Italy. | Finance |
Roca Therapeutics SAS
Roca Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Roca Therapeutics SAS is a French company that engages in research and drug development in the fields of oncology, ophthalmology, and immunology. The company is based in Nice, France. The company was founded in 2021. The CEO is Maeva Dufies. | Commercial Services |
